Characterizations of clinical isolates of Clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: A multicenter study in Taiwan

Liao C.-H.Ko W.-C.Lu J.-J.PO-REN HSUEH2020-12-182020-12-1820120066-4804https://scholars.lib.ntu.edu.tw/handle/123456789/528448Characterizations of clinical isolates of Clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: A multicenter study in Taiwanjournal article10.1128/AAC.00191-12225082992-s2.0-84862525707